TransCode Therapeutics In... (RNAZ)

2.00

-0.52 (-20.63%)

At close: Feb 28, 2025, 3:59 PM

1.94

-2.95%

Pre-market: Mar 03, 2025, 04:35 AM EST

TransCode Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-18.55M	-17.56M	-6.84M	-2.34M	-607.21K	-453.44K
Depreciation & Amortization	516.75K	98.61K	42.47K	n/a	n/a	n/a
Stock-Based Compensation	1.04M	395.33K	186K	45.44K	1.4K	22.38K
Other Working Capital	-146.27K	-535.2K	-1.85M	118.51K	50.04K	24.94K
Other Non-Cash Items	n/a	-890.95K	39.47K	1.5M	102.01K	106.55K
Deferred Income Tax	n/a	890.95K	876.19K	n/a	n/a	n/a
Change in Working Capital	-1.08M	1.31M	432.39K	309.76K	-4.7K	24.94K
Operating Cash Flow	-18.07M	-15.76M	-5.27M	-492.97K	-508.51K	-299.57K
Capital Expenditures	-35.61K	-100.92K	-254.82K	n/a	n/a	n/a
Acquisitions	n/a	n/a	3K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-100.92M	3.00	n/a	n/a	n/a
Investing Cash Flow	-35.61K	-100.92K	-251.82K	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	1.19M	500K	550K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	5.99K	-818.55K	-73.48K	n/a	-37.57K
Financial Cash Flow	15.91M	5.99K	25.52M	1.12M	500K	512.43K
Net Cash Flow	-2.2M	-15.86M	20M	623.54K	-8.51K	212.86K
Free Cash Flow	-18.11M	-15.86M	-5.52M	-492.97K	-508.51K	-299.57K